Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/2003
05/07/2003CN1107456C Instant food for preventing and treating hyperlipomia and its preparing process
05/06/2003US6559315 Phenyl- and pyridyl-substituted thiazoline acid derivatives useful in diagnosing and treating pathological conditions associated with an excess of trivalent metals in humans and animals.
05/06/2003US6559293 Topiramate sodium trihydrate
05/06/2003US6559289 Use of growth hormone or analogues thereof for the treatment of mammals with familial hypercholesterolemia
05/06/2003US6559187 For treating hyperglycemia and diabetes
05/06/2003US6559185 Nitromethyl ketone compounds having aldose reduction inhibiting properties and methods for their use
05/06/2003US6559168 Thiazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
05/06/2003US6559160 These compounds and compositions bind to the CXCR3 chemokine receptor and are useful for treating diseases and conditions responsive to the modulation of CXCR3 activity, such as multiple sclerosis, rheumatoid arthritis, psoriasis, cancer,
05/06/2003US6559159 Kappa opioid receptor ligands
05/06/2003US6559148 Administering a therapeutically effective amount of a compound which is a P2Y purinoreceptor antagonist such as Basilen Blue
05/06/2003US6559147 3-((3,5-difluoro-6-(3-(1-methylimidazolin-2-yl)phenoxy)-4 -(2,3 -dihydroxypropoxy)pyridin-2-yl)oxy)-4-hydroxybenzamidine, for example
05/06/2003US6559126 Peptides blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
05/06/2003US6559122 Formulated composition
05/06/2003US6558952 Expansion of preferential pancreatic cells; generate nutrient broth, inoculate with pancreatic cells and gastrin receptor ligand, monitor propagation of pancreatic cells
05/06/2003US6558692 Over-coated chewing gum formulations
05/06/2003US6558657 Synthetic polymer, carbohydrate or protein substituted with disulfide moiety that inhibits fat hydrolysis
05/02/2003EP1306094A1 Preventives or remedies for obesity or fatty liver
05/02/2003EP1306091A2 Stimulation of beta cell proliferation
05/02/2003EP1306086A2 Use of thiazolidinediones for the treatment of atherosclerosis and eating disorders
05/02/2003EP1306085A1 2-Cyclohexyl-4-phenyl-1H-imidazole derivatives as ligands for the neuropeptide Y5 receptor
05/02/2003EP1305635A2 Methods to identify compounds that modulate rage
05/02/2003EP1305425A2 Drug metabolizing enzymes
05/02/2003EP1305419A2 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof
05/02/2003EP1305404A2 Protein phosphatases
05/02/2003EP1305399A1 Bacillus subtilis var. chungkookjang producing high molecular weight poly-gamma-glutamic acid
05/02/2003EP1305382A1 Purifying crude pufa oils
05/02/2003EP1305342A2 Human kininogen d5 domain polypeptides and their use
05/02/2003EP1305338A2 Modified peptides with increased potency
05/02/2003EP1305334A1 Urocortin proteins and uses thereof
05/02/2003EP1305312A1 Tartrate salts of thiazolidinedione derivative
05/02/2003EP1305311A1 Tartrate salt of thiazolidinedione derivative
05/02/2003EP1305310A1 Tartrate salts of thiazolidinedione derivative
05/02/2003EP1305306A2 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
05/02/2003EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
05/02/2003EP1305303A1 NOVEL FORM OF (R)- i N /i - 5-METHYL-8-(4-METHYLPIPERAZIN-1-YL)-1,2,3,4-TETRAHYDRO-2-NAPHTHYL]-4-MORPHOLINOBENZAMIDE
05/02/2003EP1305301A1 Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
05/02/2003EP1305295A1 Imidazole derivatives
05/02/2003EP1305294A2 Imidazolyl derivatives
05/02/2003EP1305293A1 Hexahydro-7-imino-1h-azepin-2-yl-hexanoic acid derivatives as inhibitors of inducible nitric oxide synthase
05/02/2003EP1305291A1 3-substituted isoquinolin-1-yl derivatives
05/02/2003EP1305285A1 N-substituted indoles useful in the treatment of diabetes
05/02/2003EP1305053A1 A medicinal aerosol formulation
05/02/2003EP1305046A2 Regulators of ppardelta (beta) and their use in the treatment of obesity and insulin resistance
05/02/2003EP1305025A1 Pharmaceutical composition comprising metformin and a 5-phenoxyalkyl-2,4-thiazolidinedione-type derivative
05/02/2003EP1305024A1 Method for treating fibrotic diseases or other indications ic
05/02/2003EP1305018A1 Method and compositions for prevention and/or treatment of diabetes and glucose modulation
05/02/2003EP1305017A1 Methods and compositions for the prevention and treatment of syndrome x
05/02/2003EP1305013A1 Preparation with vascular protective and anti-oxidative effect and use thereof
05/02/2003EP1305007A2 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
05/02/2003EP1223966B1 Use of gdnf for treating corneal defects
05/02/2003EP1221939A4 Ortho ester lipids
05/02/2003EP1213972B1 Composition comprising an alpha-amylase inhibitor and at least one physiologically acceptable compound capable of reducing intestinal absorption of "fast sugars"
05/02/2003EP1196167A4 Method of reducing neuronal injury or apoptosis
05/02/2003EP1140115B1 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents
05/02/2003EP1070058B1 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides
05/02/2003EP1025082B1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments
05/02/2003EP0979081A4 Composition and methods using an eutomer
05/02/2003EP0929578B1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
05/02/2003EP0918761B1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands
05/02/2003EP0801562B1 Pharmaceutical composition containing fenofibrate and polyglycolized glycerides
05/02/2003EP0800584B1 Arachidonic acid and methods for the production and use thereof
05/02/2003EP0724387B1 Angiotension ii receptor antagonists for the treatment of chronic anti-inflammatory diseases
05/02/2003EP0581849B1 Thiocarbamate sulfoxide composition for deterring ethanol ingestion
05/02/2003CA2411015A1 5-(alkylidene-cycloalkyl)- and 5-(alkylidene-heterocyclyl)-pyrazoles
05/02/2003CA2411011A1 5-heteroatom-substituted pyrazoles
05/02/2003CA2411009A1 Heterocyclo-alkylsulfonyl pyrazoles
05/02/2003CA2410466A1 Hydrazinyl and nitrogen oxide pyrazoles
05/02/2003CA2410364A1 5-heterocyclo-pyrazoles
05/01/2003WO2003035847A2 Il-13 mutein proteins, antibodies, compositions, methods and uses
05/01/2003WO2003035835A2 Glycoprotein compositions
05/01/2003WO2003035687A1 Nogo receptor homologues and their use
05/01/2003WO2003035684A1 Ee3-protein family and corresponding dna sequences
05/01/2003WO2003035678A2 Sperm factor sequences
05/01/2003WO2003035663A1 Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing same
05/01/2003WO2003035654A1 Phosphonic acid compounds as inhibitors of serine proteases
05/01/2003WO2003035650A1 Entry inhibitor
05/01/2003WO2003035644A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
05/01/2003WO2003035640A1 Pyrimidone compounds and pharmaceutical compositions containing the same
05/01/2003WO2003035639A1 Pyrimidine compound and medicinal composition thereof
05/01/2003WO2003035638A1 4-imidazolin-2-one compounds
05/01/2003WO2003035635A1 6-hydroxy isoflavones, derivatives and medicaments involving same
05/01/2003WO2003035626A2 Azole derivatives and pharmaceutical compositions containing them
05/01/2003WO2003035624A1 Quinoline compound
05/01/2003WO2003035622A1 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists
05/01/2003WO2003035621A1 Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them
05/01/2003WO2003035620A1 Bicyclic compound
05/01/2003WO2003035603A1 Acetic acid derivatives
05/01/2003WO2003035112A1 Enteral nutrient and process for producing the same
05/01/2003WO2003035099A1 Biphasic mixtures of glp-1 and insulin
05/01/2003WO2003035095A1 Use of histamine to treat liver disease
05/01/2003WO2003035086A1 Formulation
05/01/2003WO2003035085A1 Allium sativum bulb absolutes and therapeutic or cosmetic uses
05/01/2003WO2003035075A1 Inhibitors of human phosphatidyl-inositol 3-kinase delta
05/01/2003WO2003035068A1 Macrolides containing pharmaceutical compositions
05/01/2003WO2003035067A1 Novel dipeptidyl peptidase iv (dp-iv) inhibitors as anti-diabetic agents
05/01/2003WO2003035065A1 Benzimidazoles and analogues and their use as protein kinases inhibitors
05/01/2003WO2003035061A1 Use of indole and indoline derivatives in the treatment of obesity or for the reduction of food intake
05/01/2003WO2003035057A1 Inhibitors of dipeptidyl peptidase iv
05/01/2003WO2003035056A1 Combination of liponic acid and glutamine in food and pharmaceutical products
05/01/2003WO2003035055A1 Mch antagonists for the treatment of obesity
1 ... 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 ... 1298